Previous 10 | Next 10 |
PASADENA, Calif. , April 11, 2019 /PRNewswire/ -- Today, the FH Foundation announced the launch of the FIND HoFH program to identify individuals at risk for homozygous familial hypercholesterolemia (HoFH). The goal is to accelerate the diagnosis of this life-threatening condition. ...
From the Big Picture to Individual Stock Breakouts Last year I highlighted the Healthcare Biotech Sector Breakout and correctly forecasted "at least 20% gains in sector ETFs and even higher for many key biotech stocks in the near term." I believe the technical analysis that I will det...
SAN FRANCISCO , April 2, 2019 /PRNewswire/ -- Researchers from Invitae (NYSE: NVTA), a leading genetics company, will present data from more than 113,000 patients that support updating genetic testing guidelines to include clear recommendations for multigene panel testing in pati...
This is a special contribution article by Prof. Grant Henning based on his published research on the BLM technical theory . The model, his 2% trailing stop-loss approach, and comments are expressly based on his own proprietary methodology and forecasts. Winning Bounce/Lag Momentum Stocks...
This is a special contribution article by Prof. Grant Henning based on his published research on the BLM technical theory . The model and comments are expressly based on his own proprietary methodology and forecasts. Winning Bounce/Lag Momentum Stocks for Week 12 of 2019 The Bounce/L...
SAN FRANCISCO , March 14, 2019 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading genetics company, today announced that Sean George , co-founder and chief executive officer of Invitae, will present at the Oppenheimer 29th Annual Healthcare Conference on Wednesday, ...
SAN FRANCISCO , March 6, 2019 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA) today announced the exercise in full of the underwriters' option to purchase an additional 1,350,000 shares of its common stock at the public offering price of $19.00 per share, in connection with Invita...
Invitae Corporation (NYSE: NVTA ) has priced public offering of 9M shares of its common stock at $19.00 per share, for estimated gross proceeds of $171M. More news on: Invitae, Healthcare stocks news, Read more ...
SAN FRANCISCO , March 5, 2019 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA) today announced the pricing of an underwritten public offering of 9,000,000 shares of its common stock at a price to the public of $19 .00 per share. All of the shares are being sold by Invitae. The ...
Atlas Financial Holdings (NASDAQ: AFH ) -49% on Q4 earnings . More news on: Atlas Financial Holdings, Adamas Pharmaceuticals, Inc., China Finance Online Co. Limited, Stocks on the move, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Labcorp Announces Winning Bid for Select Assets of Invitae PR Newswire Advances Labcorp strategy to launch and scale specialty testing in areas such as oncology and rare diseases Transaction requires court approval, with confirmation expected on May 6, 2024 ...
Invitae Enters into Agreement with Labcorp for Sale of Business PR Newswire – Labcorp Selected as Winning Bidder in Court-Supervised Sale Process, Subject to Court and Regulatory Approvals – – $239 Million Cash Bid Includes Acquisition of Substantial...
Invitae Unveils New Research for Breast Cancer Patients with Variants of Uncertain Significance PR Newswire – Study findings to be presented at the 2024 American Society of Breast Surgeons Annual Meeting – SAN FRANCISCO , April 11, 2024 /PRNewsw...